Senator Hassan Presses Big Pharma Company on Anti-Competitive Practices that Boost Profits at the Expense of Cancer Patients
however, key patents on Keytruda will begin to expire, which should allow for competition from “biosimilar” products … stated that “when the composition of matter patents expire on our drug Keytruda, I fully expect